JANUS HENDERSON INVESTORS US LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.

Quarter-by-quarter ownership
JANUS HENDERSON INVESTORS US LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$28,661,000
+3.7%
270,794
-0.4%
0.02%0.0%
Q4 2016$27,635,000
+30.4%
271,970
+31.0%
0.02%
+27.8%
Q3 2016$21,196,000
-14.4%
207,684
-0.0%
0.02%
-14.3%
Q2 2016$24,775,000
+13.0%
207,721
+1.4%
0.02%
+10.5%
Q1 2016$21,932,000
-2.4%
204,796
-1.2%
0.02%0.0%
Q4 2015$22,466,000
-44.7%
207,214
-56.3%
0.02%
+5.6%
Q3 2015$40,604,000
+101.0%
474,076
+136.7%
0.02%
+5.9%
Q2 2015$20,206,000
+239.9%
200,258
+159.7%
0.02%
+240.0%
Q1 2015$5,945,00077,1000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders